We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Medicare prescription drug benefit that kicks off in 2006 could reduce the quantity of Rx drugs prescribed for low-income seniors because of the way the law is structured, according to a new report from the Kaiser Commission on Medicaid and the Uninsured.
At the urging of stent manufacturer Cordis, the Centers for Medicare & Medicaid Services (CMS) has initiated a review of its current carotid stent reimbursement policy to possibly expand coverage to high-risk patients.
The Centers for Medicare & Medicaid Services (CMS) issued a draft national coverage decision June 15 to expand Medicare coverage of positron emission tomography (PET) to beneficiaries suspected to have Alzheimer’s disease.
Devicemakers looking to maximize reimbursement for their products should focus on taking a team-oriented approach to the reimbursement process, according to reimbursement and development experts.
The FDA’s Circulatory System Devices Panel voted June 8 to not recommend approval of expanded indications for World Heart’s Novacor left ventricular assist device (LVAS).
The Centers for Medicare & Medicaid Services (CMS) has selected Trailblazer Health Enterprises and Caremark/Advance PCS to provide implementation support for the Medicare replacement drug demonstration project.
FDA approval for St. Jude Medical’s newest implantable cardiac defibrillators (ICDs) has been delayed by at least two months, prompting the company to lower its second-quarter earnings outlook.
HHS has launched an internal task force to promote the development of innovative medical technologies into applicable patient treatments utilizing drugs, biologics and medical devices.
Device manufacturers should engage Centers for Medicare & Medicaid (CMS) officials early during the FDA approval process to speed up reimbursements for their product pipeline, agency officials urged last week at AdvaMed’s annual Future of Medicare Policy for Medical Technologies conference in Baltimore, Md.
One group of devicemakers that was clearly pleased with the Centers for Medicare & Medicaid Services’ (CMS’) newly proposed inpatient rule are manufacturers of heart assist systems, which could see reimbursement payments for their products rise significantly.